Simultaneous robotic assisted laparoscopic prostatectomy (RALP) and inguinal herniorrhaphy (IHR): proof-of-concept analysis from a high-volume center.


Journal

Hernia : the journal of hernias and abdominal wall surgery
ISSN: 1248-9204
Titre abrégé: Hernia
Pays: France
ID NLM: 9715168

Informations de publication

Date de publication:
02 2020
Historique:
received: 01 01 2019
accepted: 05 03 2019
pubmed: 17 3 2019
medline: 31 12 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

Inguinal hernia (IH) is detected in approximately 33% of RALP's either pre or intraoperatively wherein all are repaired during RALP to circumvent future herniorrhaphy (Fukuta et al., Urology 68(2):267-271, 2006; Nielsen, Urology 66(5):1034-1037, 2005). Some debate this policy by quoting the potential risk of mesh lying close to the vesicourethral anastomosis leading to infections and adhesions. The current study was initiated to elucidate the feasibility and outcomes of simultaneous inguinal herniorrhaphy (IHR) during RALP. Historic analysis of prospectively maintained data of 1224 RALP patients, as per inclusion criteria, between 2012 and 2017 was done, among whom 143 patients had a concurrent IHR using 3DmaxTM polypropylene monofilament mesh. Patients were then compared for demographics, peri-operative features, and outcomes. The mean age and AUA score were significantly different (p < 0.002, p < 0.01 respectively) between patients undergoing only RALP and RALP with IHR. BMI was not significantly different. One hundred forty-three patients (11.6%) underwent IHR at 155 hernial sites, 12 sites being bilateral. One hundred and one sites (65.2%) were diagnosed intraoperatively. The mean console time was 67.4 ± 11.5 min for RALP which increased by 6.9 ± 10.7 min in unilateral and by 10.7 ± 8.6 min in bilateral IHR. There were no mesh-associated or Clavien Dindo class II-V complications. Mean follow-up was 36 ± 1.4 months with no recurrences. This study reiterates the feasibility and advisability of repairing most inguinal hernias encountered during RALP as it is without any significant alteration of peri-operative morbidity, is associated with excellent post-operative outcomes, and obviates the need for a future surgical procedure.

Identifiants

pubmed: 30877570
doi: 10.1007/s10029-019-01926-8
pii: 10.1007/s10029-019-01926-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-113

Références

J Endourol. 2016 Feb;30(2):218-22
pubmed: 26486884
Am Surg. 2015 Oct;81(10):1043-6
pubmed: 26463305
J Korean Surg Soc. 2013 Oct;85(4):175-9
pubmed: 24106684
Hernia. 2014 Apr;18(2):283-8
pubmed: 24233340
Urology. 2011 Feb;77(2):391-5
pubmed: 20646748
Int J Med Robot. 2010 Sep;6(3):311-4
pubmed: 20812271
J Endourol. 2011 Apr;25(4):625-9
pubmed: 21417751
World J Surg Oncol. 2017 Mar 16;15(1):61
pubmed: 28302122
Surg Innov. 2015 Jun;22(3):303-17
pubmed: 25270082
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
World J Urol. 2005 Sep;23(4):295-9
pubmed: 16133559
Urology. 2006 Aug;68(2):267-71
pubmed: 16904432
Urology. 2005 Nov;66(5):1034-7
pubmed: 16286119
J Urol. 2013 Mar;189(3):884-90
pubmed: 23009871
Urology. 1996 Apr;47(4):536-7
pubmed: 8638364
J Endourol. 2016 Oct;30(10):1036-1040
pubmed: 27575356
Medicine (Baltimore). 2018 Sep;97(37):e12208
pubmed: 30212952
J Endourol. 2016 Feb;30(2):208-11
pubmed: 26414558
Urol J. 2018 Nov 17;15(6):381-386
pubmed: 30033512
J Robot Surg. 2008;1(4):269-72
pubmed: 25484976
Ann Surg. 2008 Jun;247(6):1064-8
pubmed: 18520236

Auteurs

R R Bajpai (RR)

Larkin University Hospital, South Miami, FL, USA.

S Razdan (S)

Urology, Icahn School of Medicine, Mount Sinai Hospital, New York, USA.

M A Sanchez-Gonzalez (MA)

Division of Clinical and Translational Research, Larkin Community Hospital, South Miami, FL, USA.

S Razdan (S)

Director Endourology and Robotic Fellowship Program, International Robotic Prostatectomy Institute, Larkin University Hospital, Pavilion, 3650 N W 82nd Avenue, Suite 501, Doral, FL, 33166, USA. urodoc96@aol.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH